Altogether, we showed that functional Lepr is necessary for metformin treatment to be effective, and that long-term metformin treatment might promote NAFLD progression in leptin-insensitive individuals. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.